Drug profile · INN
ticarcillin disodium
TICAR
ticarcillin disodium (TICAR) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — ticarcillin disodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 40
- Data quality
- 0.84
Quick answer
ticarcillin disodium (TICAR) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is ticarcillin disodium?
ticarcillin disodium (TICAR) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ticarcillin disodium?
TICAR is a marketed brand name for ticarcillin disodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ticarcillin disodium?
ticarcillin disodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.